Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-27 Purchase |
2020-10-29 5:01 pm |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
5,500 | $16 | $88,000 | 258,397 (Direct) |
View |
| 2020-10-27 Purchase |
2020-10-29 4:58 pm |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
150,000 | $16 | $2,400,000 | 1,851,801 (Indirect) |
View |
| 2020-10-27 Purchase |
2020-10-28 06:02 am |
Foghorn Therapeutics Inc. | FHTX | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner |
150,000 | $16 | $2,400,000 | 1,231,081 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-27 Conversion |
2020-10-29 4:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
50,450 | $0 | 25,225 (Indirect) |
View |
| 2020-10-27 Conversion |
2020-10-29 4:58 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
35,693,745 | $0 | 1,851,801 (Indirect) |
View |
| 2020-10-27 Conversion |
2020-10-28 06:02 am |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner |
3,081,082 | $0 | 1,231,081 (Direct) |
View |
Ownership |
2020-10-22 9:05 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
0 | $0 | 12,524,120 (Indirect) |
View |
Ownership |
2020-10-22 9:04 pm |
N/A 2027-04-04 |
Foghorn Therapeutics Inc. | FHTX | Mendelsohn Michael Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 9:03 pm |
N/A 2028-01-30 |
Foghorn Therapeutics Inc. | FHTX | Koppel Adam Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 8:59 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | KADOCH CIGALL Director 10% Owner |
0 | $0 | 3,957,712 (Direct) |
View |
Ownership |
2020-10-22 8:58 pm |
N/A 2027-11-01 |
Foghorn Therapeutics Inc. | FHTX | GILL SIMBA Director |
0 | $0 | 189,188 (Direct) |
View |
Ownership |
2020-10-22 8:57 pm |
N/A 2030-06-04 |
Foghorn Therapeutics Inc. | FHTX | Biller Scott Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 8:56 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Baselga Jose Director |
0 | $0 | 94,594 (Direct) |
View |
Ownership |
2020-10-22 8:52 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | DECICCO CARL Chief Scientific Officer |
0 | $0 | 658,233 (Direct) |
View |
Ownership |
2020-10-22 8:50 pm |
N/A 2029-09-16 |
Foghorn Therapeutics Inc. | FHTX | Agresta Samuel Chief Medical Officer |
0 | $0 | 403,188 (Direct) |
View |
Ownership |
2020-10-22 8:49 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Reine Allan Chief Financial Officer |
0 | $0 | 403,187 (Direct) |
View |
Ownership |
2020-10-22 8:45 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks |
0 | $0 | 1,492,136 (Direct) |
View |
Ownership |
2020-10-22 6:43 pm |
N/A N/A |
Foghorn Therapeutics Inc. | FHTX | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd 10% Owner |
0 | $0 | 1,081,081 (Direct) |
View |